pancreatic cancer
Conditions
Interventions
Sponsors
Sato Junya
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patient with suspected pancreatic malignant tumor Patient with no indication of radical resection 2)Patient <=80 years 3)Patient scheduled to have a genetic panel test using tumor tissue 4)Patient with performance status <=1 according to the ECOG standard. 5)Patient with no severe disorders in major organs 6)Written informed consent
Exclusion criteria
Exclusion criteria: 1) Patient with history of radiation therapy or chemotherapy for pancreatic cancer. 2) Patient with the regular use of antithrombotic drugs that cannot be suspended during EUS-FNB 3) Patient with mental disorder 4) Inappropriate patient for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of candidate samples for NGS | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor area on a slide Accuracy rate of EUS-FNB Success rate of predetermined number of needle passes Rate of successful of one needle pass The number of needle passes Procedure time Adverse events during EUS-FNB Post-procedure adverse events Rate of passed or qualified report in patients who undergo F1CDx Rate of passed report in patients who undergo F1CDx Tumor area on a slide in patients who undergo F1CDx | — |
Contacts
Public ContactJunya Sato
Shizuoka Cancer Center
Outcome results
None listed